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Executive Summary 
Post-Operative Nausea and Vomiting Risk Assessment and Prophylaxis 
Patients who must undergo surgery with general anesthesia sometimes experience nausea 
and vomiting. This is a potential side effect of general anesthesia and is termed post-operative 
nausea and vomiting, or PONV. The screening process prior to surgery usually includes 
questions regarding previous problems with PONV; however, this only applies to patients who 
have had previous experiences with surgery and general anesthesia. Relying on a patients’ 
history of PONV alone to predict this unwanted side effect limits the providers’ ability to assess 
and prophylactically treat PONV. Assessing for risk of PONV using a pre-operative risk 
assessment tool can help to identify those who are at increased risk and potentially prevent 
PONV. Incorporating a preoperative risk screening tool as well as a prophylactic protocol based 
on risk would give providers a consistent process for screening patients without relying on a 
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history of PONV. This process would ensure patients are treated with appropriate prophylaxis to 
reduce incidence of PONV allowing for all patients to be screened rather than just in those who 
have had previous surgery. PONV has many potential complications for patients, staff, and the 
surgical facility. Even though PONV may be a side effect of anesthesia it may create an overall 
negative experience for patients, which has the potential to affect the facility’s patient 
satisfaction ratings.  
Rationale for the Project 
The incidence of PONV in surgical patients may be as high as 80% in those who are at 
high risk, with a general incidence rate of 30% for all surgeries (Gan et al., 2014). PONV may 
potentially lead to many unwanted physical and psychological complications for patients after 
surgery. For some patients, PONV may only cause a small delay in discharge time; however, for 
others, it could lead to life-threatening complications such as pulmonary aspiration, dehydration, 
increased intercranial/intraocular pressures, and wound dehiscence (Squire & Spencer, 2018). 
These Having surgery can be a source of stress for patients, however some patients fear PONV 
more than the pain from surgery (Hambridge, 2013). Psychological complications from PONV 
may include anxiety, distress, shame, embarrassment, and potentially fear of further surgeries.  
Physical and psychological complications from PONV may create an overall negative 
experience for patients, which has the potential to affect the facility’s overall patient satisfaction. 
In addition to the physical and psychological complications for patients, PONV has the potential 
to increase costs associated with surgery for the patient and the facility. Complications requiring 
an overnight stay or a transfer to the hospital from the ambulatory center will increase costs for 
patients, as well as the facility due to potential overtime for staff.  
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From their review of literature, Squire and Spencer (2018) concluded that many factors 
may potentially cause patients to be at increased risk for PONV, including type of anesthetic 
used, type and length of surgical, history of motion sickness/PONV, gender, smoking status, 
dehydration, and gastric distention. They explained that prophylactic treatment of PONV should 
be dependent on patients’ risk; however, most patients who undergo surgery are generally treated 
from PONV prophylactically. 
Literature Synthesis 
Databases were searched to find studies related to PONV, PONV risk assessment and 
prophylaxis treatment of PONV. Of the studies found information was gathered related to risk 
assessment tools used, and prophylaxis treatment guidelines. Risk assessment tools use evidence-
based risk factors to determine the patient’s simplified risk score (SRS). The risk assessment 
tools use factors such as female gender, history of PONV, history of motion sickness, non-
smoker, and postoperative opioid administration to calculate the SRS. The patients’ risk for 
PONV is based on the number of risk factors present, therefore the higher the number of risk 
factors the more likely the patient is to experience PONV (Hooper, 2015). Reduction in baseline 
risk factors that can be altered is recommended by The Society for Ambulatory Anesthesia 
(SAMBA). Risk factors that may be altered include avoidance of general anesthesia by using 
regional anesthesia, preferential use of propofol infusions, avoidance of nitrous oxide, avoidance 
of volatile anesthetics, minimization of peri-operative opioids, and adequate hydration (Gan et 
al., 2014). The ability to identify patients who are at risk for PONV is helpful however, for this 
tool to benefit the patient, and affect the incidence of PONV a prophylactic protocol is necessary 
(Kappen et al.,2014). Five out of six studies recommend screening patients pre-operatively with 
some form of SRS, and four out of six studies show a significant reduction in PONV with use of 
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the SRS. Five out of six studies show that adding a prophylaxis protocol for providers to follow 
based on the patients’ risk score showed a significant increase in administration of prophylactic 
antiemetics in high-risk patients. These studies suggest assessing risk for PONV preoperatively 
using a simplified risk score, along with a directive antiemetic prophylaxis protocol administered 
by the anesthesia providers has the potential to significantly affect the incidence of PONV in 
ambulatory surgical patients, as well as ensure prophylaxis treatment is initiated when patients 
are found to be high risk for PONV (Kappen et al., 2015; Gan et al., 2014; Pym et al., 2018; 
Smith et al., 2016; Tabrizi et al., 2018; Thomas et al., 2019). 
Project Stakeholders 
The addition of a pre-operative risk assessment for PONV would potentially benefit the 
anesthesiologist, surgeons, and post anesthesia care unit (PACU) nurses. This group of doctors 
and nurses would be the largest of the stakeholders for the proposed change.  Data for incidence 
of PONV at the center would be essential to obtain prior to the start of the project to help with 
the education and rational of the project. The administrator, clinical director, and medical 
director will be an important part of obtaining permission for completing the project. The 
medical director in this case is an anesthesiologist and may potentially be a key stakeholder for 
implementation. For this project, a directive prophylaxis protocol is needed and would have to be 
written and approved by the administration team based on evidence from literature on 
prophylaxis.  Training and education would be needed for pre-operative nurses on the risk 
assessment tool, as well as anesthesiologist for the directive prophylaxis protocol. The PACU 
nurses would see the most benefit from the reduction in PONV and would-be great leaders for 
this change. 
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Implementation Plan 
Postoperative nausea and vomiting (PONV) risk assessment should begin as the patient 
is prepared for surgery. Patients will be screened for PONV using the Apfel risk assessment tool 
to determine level of risk. The Apfel risk assessment is comprised of four questions: 1. Is the 
patient of female gender? 2. Is the patient a non-smoker? 3. Does the patient have a history of 
PONV/motion sickness?  4. Will the patient be receiving post-operative opioids? (Gan et al., 
2014). Each question with and answer of “yes”, will be equal to 1 point, with a possible total of 
4 points and about 80% risk of PONV. This risk assessment will be completed and documented 
during the first point of contact with the patient by phone when the pre-operative nurse calls to 
gather pertinent health and mediation history from the patient. If the patient is unable to be 
reached prior to the arrival at the center, the pre-operative nurse who prepares the patient for 
surgery shall obtain the risk assessment. The risk assessment will be documented on a separate 
form that will be part of the anesthesia hand off report. After a risk score has been calculated 
for the patient, the nurse will then highlight the corresponding recommended intervention on 
the prophylaxis portion of the risk assessment form. Here there will be a directive protocol for 
prophylaxis interventions based on the patients’ risk score.  This form will be placed with 
anesthesia paperwork and the risk score and corresponding recommended prophylaxis will be 
relayed during verbal report from the pre-operative nurse to the anesthesia provider. The 
anesthesia provider and the pre-operative nurse shall both sign the form acknowledging the 
information was relayed.  If the provider chooses not to follow the directed prophylaxis, they 
should complete, or circle the reason for choosing not to follow the recommendation.   
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The form will become part of the patients record and will be used to document the 
patient’s status postoperatively. The recovery nurse will document the presence of PONV in the 
recovery area and any interventions during the recovery period related to PONV.  The recovery 
nurse will document delays in care due to PONV and complications related to PONV. This 
information will be used to determine the incidence of PONV after implementation of the risk 
assessment score and directive prophylaxis. To determine if using a risk assessment and 
directive prophylaxis reduces the incidence of PONV data must be collected prior to 
implementation. The postoperative nurses will audit charts using an audit form developed to 
determine the incidence of PONV by determining the current incidence of PONV and collecting 
data for 30 days prior to the implementation of the project.  
Timetable/Flowchart 
 The project will be presented to the administration team at Baylor Surgicare Dallas where 
it will need be approved for implementation prior to collecting data. Once approval is obtained, 
staff from the post-anesthesia care unit will be introduced to the topic and a team will be formed. 
This is an important step to ensure the project is successful. Once a team is in place data 
collection will begin to find the current incidence of PONV at the facility. The goal is to collect 
at least 30-45 days of data to get a baseline incidence rate. If it is possible to go back in the 
records and collect data from previous patients this would be ideal to gain a larger pre-
implementation incidence rate of PONV. During the data collection by the project team, 
education of the staff about PONV and the rational for the project would begin. Education for all 
nurses would be completed by a member of the project team. The anesthesia providers would be 
given information about the project and the coming risk assessment tool and directive 
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prophylaxis as part of the education roll out. Once staff have received education the SRS and 
prophylaxis protocol will be implemented in the pre-operative area, and the anesthesia providers 
will have access to the directive prophylaxis protocol by email as well as the details of the 
project. The goal is to collect data for 1 month and then revisit with the team and discuss the 
implementation process to ensure barriers or process issues are addressed. At the 1-month mark 
results of the project would determine if changes need to be made to the process. Ideally the 
project would last for at least 3 months to see if the process was working to reduce the incidence 
of PONV. Assessment of data collected on incidence of PONV before and after the project was 
implemented will be reviewed. The data will need to show a change in the incidence of PONV, 
as well as the increase in use of the directive prophylaxis protocol based on risk. Data will be 
gathered from the project, as well as discussions with the team for an overall evaluation of how 
well the plan was implemented. Since the change project is unable to be implemented staff will 
be educated about PONV. The intent is to increase awareness of PONV potential complications, 
known risk factors, and identification of patients who would potentially benefit from 
prophylaxis.  
Project Phases                                                               Timeline 
Approval from administration team                                                                                 By January 1, 2021 
Meeting with staff to form project team                                                                                January 4                                                                                  
Begin PONV incidence data collection                                                                                 January 6 
Meet with team to write SRS, Directive prophylaxis/approval/ data collection tool            January 6-11 
Education for Staff on Pre-op assessment/prophylaxis                                                         January 12 
Implement SRS/Prophylaxis directive                                                                                  February 15 
Team meeting discuss implementation process/barriers                                                       February 22 
Final team meeting/ data collection ends                                                                               March 26 
Data analysis/discuss issues with change implementation/refine process                             March 26- April 2 
Complete project                                                                                                                    April 26 
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Data Collection Methods 
The incidence of PONV in ambulatory surgical patients at Baylor Scott and White 
Surgicare Dallas would be measured prior to beginning the project. This data will then be 
compared to the data collected after the implementation of a risk assessment tool to determine 
the patient’s risk for PONV, as well as a directive prophylaxis protocol to be used by the 
anesthesia providers. Risk assessment tools use evidence-based risk factors to determine the 
patient’s simplified risk score (SRS). The risk assessment tools use factors such as female 
gender, history of PONV, history of motion sickness, non-smoker, and postoperative opioid 
administration to calculate the SRS. The patients’ risk for PONV is based on the number of risk 
factors present, therefore the higher the number of risk factors the more likely the patient is to 
experience PONV (Hooper, 2015). The ability to identify patients who are at risk for PONV is 
helpful however, for this tool to benefit the patient, and affect the incidence of PONV a 
prophylactic protocol is necessary (Kappen et al.,2014). Once both tools are implemented the 
incidence rates of PONV in the ambulatory patients would again be measured to determine if 
there was any change in the incidence rates of PONV with use of the tools.  
Within the data collected the use of the directive prophylaxis protocol would also be key 
to determine if the recommendations based on the patient’s risk score were followed through 
with prophylaxis. This would help to determine if the protocols created for prophylaxis are 
effective against PONV, and ensure they are being utilized with high-risk patients. A team would 
also be created to debrief with anesthesia providers using the directive prophylaxis to gather 
feedback about the protocol and determine if there need to be changes made based on use and 
effect on PONV incidence. Once the data is collected and analyzed to see effect on incidence of 
PONV the project will then need to be reviewed for potential changes with the key stakeholders.  
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  The data will need to show a change in the incidence of PONV, as well as the use of the 
directive prophylaxis protocol based on risk. Data will be gathered from the project, as well as 
discussions with the team for an overall evaluation of how well the plan was implemented. If the 
change project is unable to be implemented staff will be educated about PONV. The intent would 
be to increase awareness of PONV potential complications, known risk factors, and identification 
of patients who would potentially benefit from prophylaxis.   
Cost/Benefit Discussion 
The costs associated with this plan should be minimal, at most it would be an increase 
use of antiemetic medications, which could potentially be offset by decreased 
complications/recovery time. The benefit of reducing incidence of PONV would be to decrease 
the amount of overtime for the recovery department. When patients experience PONV recovery 
time is increased, and this has a potential to increase workload for the recovery nurses. With 
more time spent caring for patients who are nauseated or vomiting, this can take time away from 
other patients as well as increase the time it takes to discharge other patients the nurse is caring 
for. If PONV incidence is reduced the workflow for nurses can be maintained which will ensure 
that patients discharge time is not delayed and staffing is appropriately maintained for the day. 
Discussion of Results 
 PONV will continue to be a problem in surgical patients. Ambulatory centers such as 
Baylor Surgicare could benefit from ensuring all steps are taken to reduce the incidence of 
PONV. At this time, the project was not able to be implemented however, I do think it brought 
awareness to the issue and has potential for implementation in the future. This time has been a 
struggle for staff and the center while trying to recover from the time lost during the furlough of 
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staff and the center being closed for operation for over a month during the pandemic. The center 
is also in the middle of a transition from operating out of two separate facilities and now has 
combined both centers of employees and procedures to one building. This has been a time of 
challenge for the staff and administration and unfortunately not an ideal time for an 
implementation project. When the time is appropriate, and data collection of the incidence of 
PONV can be obtained, it is my belief findings will be significant enough to warrant an 
exploration of current practices. At that time the evidence of PONV risk assessments can be 
added to the pre-operative process and a prophylactic protocol can be developed and 
implemented, and I feel the findings will support a need for practice change. 
Conclusions/Recommendations 
 Patients who experience PONV have the potential to experience life-threatening physical 
and psychological complications. PONV may also create an increase in the costs of care for 
patients as well as facilities by prolonging recovery time. Understanding that PONV is not only a 
nuisance for patients but can even lead to life threatening complications such as aspiration and 
wound dehiscence, it becomes a very hard topic to ignore. Using a risk assessment tool to 
identify patients at risk for PONV along with the use of a directive prophylactic treatment 
protocol has the potential to reduce the incidence of PONV. Evidence is clear patients do not 
want to experience PONV as well as the surgeons, anesthesiologist, and any nurses responsible 
for care want to do what is possible to prevent it from occurring. Following evidence-based 
practice for prevention of PONV may help providers to identify those who are at risk and 
decrease the chances of occurrence in some cases. Currently in the ambulatory surgery center 
there are no specific guidelines or directives that dictate what prophylaxis medications a patient 
may get, and there is no specific tool or risk assessment used to identify patients who are at risk 
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for PONV. All methods used to identify and assess need for prophylaxis and even what type of 
prophylaxis is left up to the anesthesiologist at this time. Following systematic process using 
evidence-based practice to identify risks and treat with the appropriate prophylaxis has the 
potential to reduce the incidence of PONV according to Gan et al., 2014. With this the 
conclusion of the data collected it seems PONV incidence rates should be explored as well as a 
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Appendix A: Evaluation Table 
PICOT Question: In ambulatory surgical patients receiving general anesthesia (P) how does utilizing a pre-operative risk 
assessment tool for post-operative nausea and vomiting along with a directive prophylaxis protocol (I) compared to no risk 
assessment tool or protocol (C) affect the incidence of post-operative nausea and vomiting (O) in the first twenty-four hours after 
surgery (T)? 
 
PICOT Question Type (Circle): Intervention   Etiology    Diagnosis or Diagnostic Test    Prognosis/Prediction   Meaning 
 
Caveats  
1) The only studies you should put in these tables are the ones that you know answer your question after you have done rapid 
critical appraisal (i.e., the keeper studies) 
2) Include APA reference 
3) Use abbreviations & create a legend for readers & yourself 
4) Keep your descriptions brief – there should be NO complete sentences 
5) This evaluation is for the purpose of knowing your studies to synthesize. 
 
Place your APA Reference here (Use correct APA reference format including the hanging indentation):  
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superior to the care-as -usual 
phase 
-adherence to the therapeutic 
recommendations was not 100% 
-feasible for use In practice 
 
Low risk of harm 
Level of evidence: 4 
USPSTF: Grade B 
Level of certainty: low  
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Appendix A: Continued 
















































group             
n =3768 
Implement
ation group  



















































Incidence of PONV 





Both genders had 
decreased Incidence 
PONV  
males: (Χ2= 4.52, p = 
0.03) 
females: (Χ2= 14.4, p 
= 0.00014)  
Incidence of PONV 
implementation 








-Design of the study- difficult to extract 
data from health record if not noted or 
addressed. Only interpretation of 
patient’s health record since some 
criteria was not specifically addressed. 
-limitation on time frame PONV 
present since only monitored in pacu 
and discharge, not on inpatients. 
-historical sample was unable to obtain 
some information that is needed to 
complete the risk assessment like 
motion sickness. 
- Historical sample only able to gather 
PONV incidence based on medications 
given, not an interaction or question of 
presence of PONV 
Low risk of harm 
Level of evidence: 6 
USPSTF: Grade B 
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Χ2 Incidence of PONV 
significantly 
decreased int the 
posimplementation 











incidence of PONV 
with general 
anesthesia 21% to 
10% 
statistically significant evidence 
strengths-able to successfully 
implement risk stratification and 
targeted prophylaxis that was 
easily adopted by staff and 
providers 
Limitations-manual chart 
review/data collection, small 
sample size, only specific surgery 
type, limited staff education  
Low risk of harm 
Level of evidence: 6 
 
USPSTF: Grade B 
 
Level of certainty: low 
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tool to guide 
prophylaxis 













































(t = 3.96; df = 298.9; 





Incidence of PONV 





to 29%  
postimplemenation  
Strengths:  Risk assessment tool 
identified moderate to high risk 
patients and helped to increase 
prophylaxis 
Limitations: small sample size, 
limited to gynecologic surgery, and 
female only patients.  Female 
gender is an independent risk 
factor for PONV. Compliance from 
providers who are responsible for 
administering prophylaxis 
Risk: None stated 
Feasibility: use to assess risk for 
PONV in surgical patients. 
Level of evidence: 6 
USPSTF: Grade B 
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Appendix A: Continued 







































































































Identification of risk 
factors that increase 
risk of  PONV; 




history of motion 
sickness, duration of 
anesthesia, use of 
volatile anesthetics, 
and nitrous oxide. 
Reducing risk factors 
to reduce incidence 
of PONV 











Strengths:   
Limitations: inadequate literature. 
Unable to assess if relationship 
between interventions and 
outcomes. 
Risk: None stated 
Feasibility: use for risk assessment  
and treatment prophylaxis 
Level of evidence: 1 
USPSTF: Grade B 
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Apfel and Koivuranta 
both showed 
significant difference 
between use of the 
scoring systems and 
PONV  
Strengths:   
Limitations: Small sample size 
Risk: None stated 
Feasibility: use for risk assessment 
and treatment prophylaxis 
Level of evidence: 1 
USPSTF: Grade B 
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Appendix A: Continued 








Zhang, K., & 
Cakmakkay













































































Strengths:   
Limitations: none stated 
Risk: None stated 
Feasibility: use for risk assessment 
and treatment prophylaxis 
Level of evidence: 1 
USPSTF: Grade B 
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Volatile anesthetics = 
1.82 
Age= 0.88 
Female gender= 2.57 
 
Strengths:   
Limitations: English language only 
Risk: None stated 
Feasibility: use for risk assessment 
and treatment prophylaxis 
Level of evidence: 3 
USPSTF: Grade B 
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Appendix A: Continued 
Wu, Y. H., 











































































Female p= <0.001 





Strengths:   
Limitations: only enrolled 
Taiwanese patients from one 
tertiary hospital in Taiwan. Patients 
were scheduled for major surgery, 
may not apply to younger 
population patients were 
scheduled for longer surgeries and 
endotracheal intubation. 
Risk: None stated 
Feasibility: use for risk assessment 
and treatment prophylaxis 
Level of evidence: 1 
USPSTF: Grade B 








PONV RISK ASSESSMENT      29 
















































































admission to CSICU= 
3.57 
Intra operative 
steroid use= 3.23 
Strengths:   
Limitations: retrospective design  
small sample size 
Risk: None stated 
Feasibility: use for risk assessment 
and treatment prophylaxis 
Level of evidence: 1 
USPSTF: Grade B 
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tomies at a 
outpatient 














 Family HX of PONV =  
P < 0.01 
Hx of motion sickness 
P = 0.02 
   
Strengths:   
Limitations: use of dexamethasone, 
limited to one type of procedure, 
and protocolized anesthesia 
techniques  
Risk: None stated 
Feasibility: use for risk assessment 
and treatment prophylaxis 
Level of evidence: 1 
USPSTF: Grade B 
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Appendix A: Continued 
 
Legend: 
PONV- Post operative nausea and vomiting 
PACU- Post anesthesia care unit 
MS- Motion sickness 
GA- General anesthesia 
M- mean 
Χ2 –  chi square test 
t- t-test  
OR- Odds ratio 
CI- confidence interval 
R2- regression analysis 
DDSP for AP- directive decision support tool for antiemetic prophylaxis 
***Prompts for each column – please do not repeat the headings, just provide the data                                                                                   
Used with permission, © 2007 Fineout-Overholt 
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Appendix C: Apfel risk assessment tool Directive prophylaxis protocol 
PONV prophylaxis guidelines 
Determine the number of risk factors for PONV using risk score from Apfel. 
Risk Factors Points 
Female Gender 1 
Non-Smoker 1 
History of PONV/Motion sickness 1 
Post-operative opioids 1 
Risk Score Total 0-4 
Prophylaxis bases on risk score total __________ 
Risk Score Prevalence of 
PONV 
Prophylaxis: # of 
antiemetics 
Examples 
0 9% 0-1 Ondansetron 4mg 
1 20% 1 Ondansetron 4mg          
± Dexamethasone 4mg 
2 39% 2 Ondansetron 4mg          
+ Dexamethasone 4mg  
+ Propofol infusion 
3 60% 3 Ondansetron 4mg           
+ Dexamethasone 4mg  
+ Propofol                      
± Scopolamine patch 
4 78% 4 Ondansetron 4mg                
+ Dexamethasone 4mg        
+ Propofol infusion           
+ Scopolamine patch 
 
**Drug Combinations should be with drugs that have different mechanisms of 
action. 
